Epstein-Barr Virus (EBV)-Specific T Cells as Therapy for Relapsed/Refractory EBV-positive Lymphomas

NCT00779337 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
8
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Queensland Institute of Medical Research

Collaborators